What's Happening?
Oregon Health & Science University (OHSU) has been awarded an $8 million grant from the National Institutes of Health (NIH) to establish a state-of-the-art Biosafety Level 3 (BSL-3) laboratory on its Marquam Hill campus. This funding, provided through
the NIH’s C06 Research Facilities Construction program, will facilitate the renovation of existing research space into a modern, high-containment facility. The new BSL-3 lab is designed to enhance research capabilities for dangerous pathogens and emerging infectious diseases, replacing OHSU’s current BSL-3 laboratory, which is over 30 years old and limited in its capacity for contemporary infectious disease research. Fikadu Tafesse, Ph.D., professor and chair of microbiology and immunology in the OHSU School of Medicine, led the grant application effort, emphasizing the critical need for a larger, safer facility in light of the COVID-19 pandemic. The total project cost is approximately $18 million, with OHSU contributing the remaining $10 million. The new facility will feature four dedicated research suites, two animal research suites, shared equipment areas, pass-through autoclaves, and changing facilities for researchers, and is expected to take about three years to complete.
Why It's Important?
This investment is crucial for strengthening the U.S.'s defense against future infectious disease outbreaks. The COVID-19 pandemic highlighted the urgent need for robust research infrastructure to understand and combat emerging pathogens. By modernizing its BSL-3 laboratory, OHSU will significantly expand its capacity to conduct cutting-edge research on viruses like tuberculosis, yellow fever virus, and SARS-CoV-2. This enhanced capability will allow for faster development of vaccines and treatments, which are often lacking for new pathogens. The facility will also incorporate New Approach Methodologies (NAMs), such as organoids and advanced human tissue models, to reduce reliance on animal studies and accelerate the research process. This not only positions OHSU as a leader in infectious disease research but also serves as a regional asset, providing critical resources for research partners without access to their own BSL-3 laboratories. Ultimately, this initiative aims to save lives and reduce the burden of infectious diseases on the healthcare system by enabling quicker and more effective responses to public health threats.
What's Next?
The construction of the new BSL-3 laboratory at OHSU is anticipated to take approximately three years. During this period, OHSU will continue to plan and execute the renovation of the existing research space to meet modern BSL-3 design standards. Once operational, the facility will become an institutional resource for investigators across OHSU and a regional asset for research partners, fostering increased collaboration and scientific discovery. The integration of New Approach Methodologies (NAMs) will likely lead to more efficient and ethically sound research practices. The success of this project could also influence future funding decisions and encourage other institutions to invest in similar infrastructure upgrades, further bolstering national preparedness for pandemics. Researchers like Bill Messer, M.D., Ph.D., whose lab studies mosquito-borne viruses, expect the new facility to streamline their work, allowing projects to be conducted from beginning to end in one location, thereby saving time and reducing costs.
Beyond the Headlines
The establishment of this advanced BSL-3 laboratory at OHSU represents a broader shift in national strategy towards proactive pandemic preparedness, moving beyond reactive responses. It underscores a recognition that continuous investment in scientific infrastructure and research is paramount for national security and public health. The emphasis on integrating NAMs also highlights an evolving ethical landscape in scientific research, aiming to reduce animal testing while improving the relevance of research to human health. This facility will not only enable the study of known dangerous pathogens but also provide the flexibility to rapidly pivot to newly emerging threats, reflecting a long-term vision for public health resilience. The collaboration between OHSU and the NIH, along with the university's significant financial contribution, signals a collective commitment to safeguarding the population against future biological crises, fostering a culture of preparedness that extends beyond immediate threats.
